Literature DB >> 3111621

Myocardial infarction due to amphetamine.

P Carson, K Oldroyd, K Phadke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111621      PMCID: PMC1246676          DOI: 10.1136/bmj.294.6586.1525

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Propylhexedrine-induced left ventricular dysfunction.

Authors:  C H Croft; B G Firth; L D Hillis
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

2.  Acute cardiomyopathy secondary to intravenous amphetamine abuse.

Authors:  T D Call; J Hartneck; W A Dickinson; C W Hartman; A G Bartel
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

3.  Acute amphetamine cardiomyopathy in a drug addict.

Authors:  M E O'Neill; L F Arnolda; D M Coles; G Nikolic
Journal:  Clin Cardiol       Date:  1983-04       Impact factor: 2.882

4.  Cardiomyopathy associated with amphetamine administration.

Authors:  H J Smith; A H Roche; M F Jausch; P B Herdson
Journal:  Am Heart J       Date:  1976-06       Impact factor: 4.749

  4 in total
  4 in total

1.  Myocardial infarction associated with the use of dextrofenfluramine.

Authors:  P Evrard; A F Allaz
Journal:  BMJ       Date:  1990-08-11

2.  Cerebral infarction after excessive use of nasal decongestants.

Authors:  J Montalbán; L Ibañez; C Rodriguez; M Lopez; J Sumalla; A Codina
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

3.  Acute myocardial infarction caused by intravenous amphetamine abuse.

Authors:  G E Packe; M J Garton; K Jennings
Journal:  Br Heart J       Date:  1990-07

4.  Myocardial infarction in a pre-menopausal woman with angiographically normal coronary arteries.

Authors:  I A Khan; A W Ansari
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.